FDA Inspection
Merck Serono SA (Vevey)Merck Serono SA (Vevey) – FDA Inspection, Apr 6, 2023
Record Details
This FDA Inspection record concerns Merck Serono SA (Vevey), with an inspection on April 6, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · dc32ca15-1a57-481c-92e3-5297366fb5a5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1204345
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Merck Serono SA (Vevey)
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 30, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 15, 2016 | Not classified | Office of Inspections and Investigations | |
| February 5, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 6, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 9, 2011 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Merck Serono SA (Vevey)
- FDA Inspection 1053823 - 2018-04-30
- FDA Inspection 995521 - 2016-11-15
- FDA Inspection 964102 - 2016-02-05
- FDA Inspection 811116 - 2012-11-06
- FDA Inspection 732618 - 2011-06-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.